Nutra Pharma annual capital expenditures (capex)
2010
2011
2012
2014
2015
2016
2017
2020
2021
2022
2025
Nutra Pharma Capital Expenditures (CapEx) Growth & History (NPHC)
Nutra Pharma's capital expenditures (capex) was $26,052 for fiscal 2025.
View full Nutra Pharma company overviewNutra Pharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $26,052 | — | — |
| 2022 | 2022-12-31 | $57,993 | $18,950 | +48.54% |
| 2021 | 2021-12-31 | $39,043 | $33,138 | +561.19% |
| 2020 | 2020-12-31 | $5,905 | — | — |
| 2017 | 2017-12-31 | $9,113 | $5,731 | +169.46% |
| 2016 | 2016-12-31 | $3,382 | $2,664 | +371.03% |
| 2015 | 2015-12-31 | $718 | −$20,832 | −96.67% |
| 2014 | 2014-12-31 | $21,550 | — | — |
| 2012 | 2012-12-31 | $0 | −$1,360 | — |
| 2011 | 2011-12-31 | $1,360 | −$70,642 | −98.11% |
| 2010 | 2010-12-31 | $72,002 | — | — |
Nutra Pharma quarterly capital expenditures (capex)
Q3.10
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q1.15
Q2.15
Q3.15
Q4.15
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $26,052 | — | — |
| Q4 2022 | 2022-12-31 | $0 | −$4,275 | — |
| Q3 2022 | 2022-09-30 | $0 | −$4,604 | — |
| Q2 2022 | 2022-06-30 | $0 | −$20,214 | — |
| Q1 2022 | 2022-03-31 | $57,993 | $48,043 | +482.84% |
| Q4 2021 | 2021-12-31 | $4,275 | — | — |
| Q3 2021 | 2021-09-30 | $4,604 | — | — |
| Q2 2021 | 2021-06-30 | $20,214 | — | — |
| Q1 2021 | 2021-03-31 | $9,950 | — | — |
| Q4 2015 | 2015-12-31 | $0 | — | — |
| Q3 2015 | 2015-09-30 | $0 | — | — |
| Q2 2015 | 2015-06-30 | $0 | — | — |
| Q1 2015 | 2015-03-31 | $718 | — | — |
| Q1 2013 | 2013-03-31 | $0 | $0 | — |
| Q4 2012 | 2012-12-31 | $0 | — | — |
| Q3 2012 | 2012-09-30 | $0 | $0 | — |
| Q2 2012 | 2012-06-30 | $0 | — | — |
| Q1 2012 | 2012-03-31 | $0 | — | — |
| Q3 2011 | 2011-09-30 | $0 | −$3,459 | — |
| Q3 2010 | 2010-09-30 | $3,459 | — | — |
Nutra Pharma capital expenditures (capex) trends
Over the last five fiscal years, Nutra Pharma's capital expenditures (capex) increased from $5,905 to $26,052, a change of $20,147. The latest reported quarter, Q4 2025, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nutra Pharma source filings ↗